Clinical Trial Update: This Study is Randomised, Single Oral Dose Bioequivalence Study of Meloxicam GSK 15 MG Tablets. [NA]

View source ↗

Summary

A randomized, single-dose bioequivalence study of Meloxicam GSK 15 mg tablets.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Meloxicam GSK 15 mg tablets (meloxicam)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Arthritis, Rheumatoid | NA | Status: COMPLETED | Results posted: 2017-07-17